Chair of FDA review committee for Kymriah, the first CAR-T BLA​.

10 years of FDA cellular and gene therapy review experience.

7 years of R&D experience at VIRxSYS Corp​.

Postdoctorate at UCSF​.

Ph.D. from State University of New York​.

US based.